Effects of OKM5, a monoclonal antibody to glycoprotein IV, on platelet aggregation and thrombospondin surface expression.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Blood

• Publication date

  1990-12-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1182/BLOOD.V76.12.2501.2501PMID 1702328
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion.

  1989cited by this paper
• Rapid purification and partial characterization of human platelet glycoprotein IIIb. Interaction with thrombospondin and its role in platelet aggregation.

  1989cited by this paper
• A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes.

  1989cited by this paper
• Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor.

  1989cited by this paper
• CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes.

  1989cited by this paper
• Heparan sulfate-mediated binding of epithelial cell surface proteoglycan to thrombospondin.

  1989cited by this paper
• Isolation and characterization of platelet glycoprotein IV (CD36).

  1989cited by this paper
• Thrombospondin promotes platelet aggregation.

  1988cited by this paper
• Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors

  1988cited by this paper
• Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets.

  1988cited by this paper
• USE OF A MONOCLONAL ANTIBODY TO MEASURE THE SURFACE EXPRESSION OF THROMBOSPONDIN FOLLOWING PLATELET ACTIVATION

  1987cited by this paper
• Interactions of thrombospondin with endothelial cells: receptor- mediated binding and degradation

  1987cited by this paper
• Isolation of the thrombospondin membrane receptor.

  1987cited by this paper
• Divalent cation-dependent and independent surface expression of thrombospondin on thrombin-stimulated human platelets.

  1987cited by this paper
• Monoclonal antibodies and human blood platelets

  1987cited by this paper
• Plasminogen interacts with human platelets through two distinct mechanisms.

  1986cited by this paper
• Interaction of thrombospondin with resting and stimulated human platelets.

  1986cited by this paper
• Identification of a new class of inducible receptors on platelets. Thrombospondin interacts with platelets via a GPIIb-IIIa-independent mechanism.

  1986cited by this paper
• Characterization of a platelet membrane protein of low molecular weight associated with platelet activation following binding by monoclonal antibody AG-1.

  1986cited by this paper
• Monoclonal antibodies to human platelet glycoprotein IIb beta that initiate distinct platelet responses.

  1985cited by this paper
• Monoclonal antibody OKM5 inhibits the in vitro binding of Plasmodium falciparum-infected erythrocytes to monocytes, endothelial, and C32 melanoma cells.

  1985cited by this paper
• Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated human platelets.

  1985cited by this paper
• A monoclonal anti-human platelet antibody: a new platelet aggregating substance.

  1985cited by this paper
• Role of thrombospondin in platelet aggregation.

  1984cited by this paper
• Evidence that three adhesive proteins interact with a common recognition site on activated platelets.

  1984cited by this paper
• Monoclonal anti-human monocyte antibodies OKM1 and OKM5 possess distinctive tissue distributions including differential reactivity with vascular endothelium.

  1984cited by this paper
• Platelet-collagen adhesion: inhibition by a monoclonal antibody that binds glycoprotein IIb

  1984cited by this paper
• Patterns of antigenic expression on human monocytes as defined by monoclonal antibodies.

  1983cited by this paper
• THE FIBRINOGEN‐DEPENDENT PATHWAY OF PLATELET AGGREGATION *

  1983cited by this paper
• Complex formation of platelet thrombospondin with fibrinogen.

  1982cited by this paper
• Inhibition of fibrinogen binding to human platelets by the tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline.

  1982cited by this paper
• Specific and saturable binding of plasma fibronectin to thrombin-stimulated human platelets.

  1981cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation.

  1980cited by this paper
• Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP.

  1980cited by this paper
• Human Platelets Possess an Inducible and Saturable Receptor Specific for Fibrinogen

  1979cited by this paper
• Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

  1978cited by this paper
• Detection of Actomyosin-type Protein at the Surface of Dissociated Embryonic Chick Cells

  1970cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Specific and Saturable Binding of Plasma Fibronectin to Thrombin-stimulated Human Platelets ”

  year unknowncited by this paper

• CD36 tango in cancer: signaling pathways and functions

  2019cites this paper
• Integrin αIIbβ3

  2019cites this paper
• Targeting CD36 as Biomarker for Metastasis Prognostic: How Far from Translation into Clinical Practice?

  2018cites this paper
• Rôle des lipides oxydés dans la régulation de l'activation plaquettaire par les lipoprotéines de haute densité (HDL) plasmatiques et implication dans le diabète de type 2

  2015cites this paper
• Polysialic Acid and Polysialylation to Modulate Antibody Pharmacokinetics

  2012cites this paper
• antibodies is subtype-dependent Human platelet aggregation by murine monoclonal antiplatelet

  2011cites this paper
• CD36 as a multiple-ligand signaling receptor in atherothrombosis.

  2011cites this paper
• monocytes, platelets, and endothelial cells Normal human erythrocytes express CD36, an adhesion molecule of

  2011cites this paper
• Oxidized LDL-Activated Platelets Induce Vascular Inflammation

  2010cites this paper
• The role of platelets in the pathogenesis of cerebral malaria

  2010cites this paper
• Bedeutung der Scavenger-Rezeptoren CD36 und MSR-A für die Schaumzellbildung in der Atherosklerose

  2010cites this paper
• Syndrome métabolique et diabète chez l'Homme. Composition lipidique et oxydation des lipoprotéines de basse densité (LDL) plasmatiques en relation avec l'activation des plaquettes sanguines.

  2010cites this paper
• Bedeutung der Scavenger-Rezeptoren CD36 und MSR-A für die Schaumzellbildung in der Atherosklerose

  2010cites this paper
• Thrombotic thrombocytopenic purpura and adult onset Still's disease.

  2009cites this paper
• Hypercoagulabilité associée aux anticorps anti-phospholipides : approches descriptives et mécanistiques

  2008cites this paper
• Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis.

  2008cites this paper
• A Specific CD36-Dependent Signaling Pathway Is Required for Platelet Activation by Oxidized Low-Density Lipoprotein

  2008cites this paper
• Novel mechanistic concept of platelet inhibition

  2008cites this paper
• The role of integrin-mediated cell adhesion in atherosclerosis: pathophysiology and clinical opportunities.

  2008cites this paper
• Chapter 12 – Integrin αIIbβ3

  2007cites this paper
• High P-selectin expression and low CD36 occupancy on circulating platelets are strong predictors of restenosis after coronary stenting in patients with coronary artery disease

  2007cites this paper
• Platelets and endothelial cells.

  2007cites this paper
• The association between CD36 and Lyn protein tyrosine kinase is mediated by lipid.

  2006cites this paper
• Endothelial scavenger receptors.

  2006cites this paper
• Antibody cross-linking of human platelet P-selectin induces calcium entry by a mechanism dependent upon Fcγ receptor IIA

  2004cites this paper
• Signal regulators in FcR-mediated activation of leukocytes?

  2004cites this paper
• Platelet Activation and Inhibition of Malarial Cytoadherence by the Anti-CD 36 IgM Monoclonal Antibody NL 07

  2003cites this paper
• Polysialic Acid in Human Milk

  2003cites this paper
• A Carboxy Terminal Truncation Mutant of CD36 Is Secreted and Binds Thrombospondin: Evidence for a Single Transmembrane Domain

  2002cites this paper
• The terminal six amino-acids of the carboxy cytoplasmic tail of CD36 contain a functional domain implicated in the binding and capture of oxidized low-density lipoprotein.

  2002cites this paper
• Modulation of platelet caspases and life‐span by anti‐platelet antibodies in mice

  2002cites this paper
• CD36 associates with CD9 and integrins on human blood platelets.

  2001cites this paper
• Echicetin, a GPIb-binding snake C-type lectin from Echis carinatus, also contains a binding site for IgMkappa responsible for platelet agglutination in plasma and inducing signal transduction.

  2001cites this paper
• CD 36 associates with CD 9 and integrins on human blood platelets

  2001cites this paper
• Scavenger receptor regulation and atherosclerosis

  2000cites this paper
• The integrins alpha3beta1 and alpha6beta1 physically and functionally associate with CD36 in human melanoma cells. Requirement for the extracellular domain OF CD36.

  2000cites this paper
• Changes in Glycoprotein Expression after Platelet Activation: Differences between In Vitro and In Vivo Studies

  2000cites this paper
• The Integrins α3β1and α6β1Physically and Functionally Associate with CD36 in Human Melanoma Cells: REQUIREMENT FOR THE EXTRACELLULAR DOMAIN OF CD36

  2000cites this paper
• A review and proposed nomenclature for major proteins of the milk-fat globule membrane.

  2000cites this paper
• Cloning of the human platelet F11 receptor: a cell adhesion molecule member of the immunoglobulin superfamily involved in platelet aggregation.

  2000cites this paper
• Scavenger Receptors and Modified Lipoproteins: Fatal Attractions?

  2000cites this paper
• Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects.

  1999cites this paper
• Platelet–collagen interactions: membrane receptors and intracellular signalling pathways

  1999cites this paper
• Assignment of disulfide bridges in bovine CD36.

  1998cites this paper
• Active Lyn protein tyrosine kinase is selectively enriched within membrane microdomains of resting platelets.

  1998cites this paper
• A novel anti-platelet monoclonal antibody induces mouse platelet aggregation through an Fc receptor-independent mechanism.

  1998cites this paper
• Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages.

  1998cites this paper
• Cytokines, adhesion molecules, antiendothelial cell autoantibodies and vascular disease.

  1997cites this paper
• The Platelet Antigens CD9, CD42 and Integrin αIIbβIIIa Can be Topographically Associated and Transduce Functionally Similar Signals

  1997cites this paper
• Stimulation of Platelet Activation and Aggregation by a Carboxyl-terminal Peptide from Thrombospondin Binding to the Integrin-associated Protein Receptor*

  1997cites this paper
• Vascular Biology of CD36: Roles of this New Adhesion Molecule Family in Different Disease States

  1997cites this paper
• Systemic lupus erythematosus, thrombocytopenia, microangiopathic haemolytic anaemia and anti-CD36 antibodies.

  1997cites this paper
• The platelet antigens CD9, CD42 and integrin alpha IIb beta IIIa can be topographically associated and transduce functionally similar signals.

  1997cites this paper
• Proteolytic cleavage of the beta1 subunit of platelet alpha2beta1 integrin by the metalloproteinase jararhagin compromises collagen-stimulated phosphorylation of pp72.

  1997cites this paper
• Role of platelet adhesion in homeostasis and immunopathology.

  1997cites this paper
• Thrombospondin Induces Dimerization of Membrane-Bound, but not Soluble CD36

  1997cites this paper
• Thrombspondin Acts via Integrin-associated Protein to Activate the Platelet Integrin αIIbβ3 *

  1997cites this paper
• analysis of CD9, CD32 and p67 signalling: use of degranulated platelets indicates direct involvement of CD9 and p67 in integrin activation

  1997cites this paper
• Characterization of two vaccinia CD36 recombinant-virus-generated monoclonal antibodies (10/5, 13/10): effects on malarial cytoadherence and platelet functions.

  1997cites this paper
• Proteolytic Cleavage of the β1 Subunit of Platelet α2β1 Integrin by the Metalloproteinase Jararhagin Compromises Collagen-stimulated Phosphorylation of pp72 syk *

  1997cites this paper
• Identification of a Domain (155–183) on CD36 Implicated in the Phagocytosis of Apoptotic Neutrophils*

  1996cites this paper
• Functional roles of membrane glycoprotein CD36.

  1996cites this paper
• Synthesis, Processing, and Intracellular Transport of CD36 during Monocytic Differentiation (*)

  1996cites this paper
• Arachidonic acid uptake by human platelets is mediated by CD36.

  1996cites this paper
• CD36 is spatially associated with glycoprotein IIb-IIIa (alpha IIb beta 3) on the surface of resting platelets.

  1996cites this paper
• Differential activation of human platelets induced by Fc gamma receptor II cross-linking and by anti-CD9 monoclonal antibody.

  1996cites this paper
• Identification on human CD36 of a domain (155-183) implicated in binding oxidized low-density lipoproteins (Ox-LDL).

  1996cites this paper
• Identification of a Functional Site on CD36 Involved in the Interaction Between Platelets and Collagen.

  1995cites this paper
• [Antiplatelet glycoprotein monoclonal antibodies: properties and practical value].

  1995cites this paper
• Increased platelet CD36 constitutes a common marker in myeloproliferative disorders

  1995cites this paper
• The Analysis of Ligand-Receptor Interactions in Platelet Activation

  1995cites this paper
• Anti-Platelet Antibody Interactions with Fcγ Receptor

  1995cites this paper
• A Structural/Functional Domain on Human CD36 Is Involved in the Binding of Anti-Nakα Antibodies

  1995cites this paper
• Identification of an immunodominant functional domain on human CD36 antigen using human-mouse chimaeric proteins and homologue-replacement mutagenesis.

  1995cites this paper
• Fc gamma II receptor-mediated platelet activation induced by anti-CD9 monoclonal antibody opens Ca2+ channels which are distinct from those associated with Ca2+ store depletion.

  1995cites this paper
• Anti-platelet antibody interactions with Fc gamma receptor.

  1995cites this paper
• Selective inhibition of platelet macroaggregate formation by a recombinant heparin-binding domain of human thrombospondin.

  1994cites this paper
• Platelet activation results in a redistribution of glycoprotein IV (CD36).

  1994cites this paper
• Anti‐CD36 antibodies in thrombotic thrombocytopenic purpura

  1994cites this paper
• src‐related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells

  1994cites this paper
• Structural organization of the gene for human CD36 glycoprotein.

  1994cites this paper
• A review of the role of platelet membrane glycoproteins in the platelet-vessel wall interaction.

  1993cites this paper
• Cloning of the cDNA Encoding Human Platelet CD36: Comparison to PCR Amplified Fragments of Monocyte, Endothelial and HEL Cells

  1993cites this paper
• Melanocytes freshly isolated from normal human skin express the cell membrane receptor for the adhesive glycoprotein thrombospondin

  1993cites this paper
• Activation of human platelets by monoclonal antibodies.

  1993cites this paper
• CD36 is a receptor for oxidized low density lipoprotein.

  1993cites this paper
• Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins.

  1993cites this paper
• Platelets deficient in glycoprotein IIIb aggregate normally to collagens type I and III but not to collagen type V.

  1993cites this paper
• Human platelet aggregation by murine monoclonal antiplatelet antibodies is subtype-dependent.

  1993cites this paper
• Platelet activation and inhibition of malarial cytoadherence by the anti-CD36 IgM monoclonal antibody NL07.

  1993cites this paper
• Autoantibodies against the platelet glycoproteins (GP) IIb/IIIa, Ia/IIa, and IV and partial deficiency in GPIV in a patient with a bleeding disorder and a defective platelet collagen interaction.

  1993cites this paper
• Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family.

  1993cites this paper
• Ultrastructural demonstration of CD36 in the alpha-granule membrane of human platelets and megakaryocytes.

  1993cites this paper
• Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain

  1993cites this paper
• Autoantibodies against the platelet glycoproteins (GP) IIb/IIIa, Ia/IIa, and IV and partial deficiency in GPIV in a patient with a bleeding disorder and a defective platelet collagen interaction

  1993cites this paper
• Platelet activation and inhibition of malarial cytoadherence by the anti-CD36 IgM monoclonal antibody NL07

  1993cites this paper
• Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36.

  1993cites this paper
• Normal human erythrocytes express CD36, an adhesion molecule of monocytes, platelets, and endothelial cells.

  1992cites this paper
• Human Platelet Activating Antibodies

  1992cites this paper
• Normal aggregations of glycoprotein IV (CD36)‐deficient platelets from seven healthy Japanese donors

  1992cites this paper